# A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US

> **NCT05407662** · — · COMPLETED · sponsor: **Bayer** · enrollment: 600 (actual)

## Conditions studied

- Chronic Kidney Disease
- Type 2 Diabetes Mellitus
- Heart Failure

## Interventions

- **OTHER:** sMRA therapies

## Key facts

- **NCT ID:** NCT05407662
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-02
- **Primary completion:** 2023-06-13
- **Final completion:** 2023-06-13
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05407662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05407662, "A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05407662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*